Mexico, with its burgeoning healthcare market and strategic geographical location, represents a pivotal gateway for medical device manufacturers seeking to expand into Latin America. However, navigati...
Mexico, with its burgeoning healthcare market and strategic geographical location, represents a pivotal gateway for medical device manufacturers seeking to expand into Latin America. However, navigating its intricate regulatory landscape, spearheaded by the Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS), can often be perceived as a daunting challenge. The good news for innovative biotech and medtech ventures is that an expedited 30-day COFEPRIS medical device approval pathway exists, offering a significant competitive advantage for rapid market entry. Understanding and leveraging this accelerated route is paramount for reducing time-to-market and capitalizing on Mexico's substantial growth potential. At bioaccess®, we specialize in demystifying these complex regulatory frameworks, providing data-driven strategies and hands-on support to ensure your medical devices not only comply with local regulations but also achieve timely approval. Our deep expertise in L…